St. John's wort found "significantly superior" to placebo for mild-to-moderate depression.
This article was originally published in The Tan Sheet
Executive Summary
ST. JOHN'S WORT "SIGNIFICANTLY SUPERIOR" TO PLACEBO FOR MILD TO MODERATE DEPRESSION in a metaanalysis conducted by Klaus Linde et al., Ludwig-Maximilians-Universitat, Munich, Germany, published in the August issue of the British Medical Journal. The analysis of 23 randomized clinical trials, representing 1,757 patients, examined studies comparing extract of St. John's wort, or hypericum perforatum, in single and combination preparations, with either placebo or standard antidepressive treatment.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning